Similar medications and substitutes for NIVOLUMAB AND RELATLIMAB-RMBW
In short: Opdualag (NIVOLUMAB AND RELATLIMAB-RMBW) belongs to the Programmed Death Receptor-1 Blocking Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Opdualag is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Opdualag in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.